TF
IMGN

Tompkins Financial’s Immunogen Inc IMGN Stock Holding History

Tompkins Financial’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,385
Closed -$51K – 547
2014
Q1 		$51K Hold
3,385
– – 0.01% 278
2013
Q4 		$50K Hold
3,385
– – 0.01% 276
2013
Q3 		$58K Hold
3,385
– – 0.02% 230
2013
Q2 		$56K Buy
+3,385
New +$54.9K 0.02% 227

Other funds holding IMGN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Tompkins Financial's IMGN Position: Q2 2014 in Review

Tompkins Financial sold out of Immunogen Inc (IMGN) in Q2 2014, closing a stake of 3,385 shares — an estimated $51K sold.

Tompkins Financial first reported a position in IMGN in Q2 2013 and held it in 4 quarters. The position peaked at $58K in Q3 2013. 137 funds tracked by Wall St. Rank hold IMGN as of Q2 2014.

  • Tompkins Financial reported no remaining Immunogen Inc position as of Q2 2014 after selling out during the quarter.
  • Tompkins Financial sold 3,385 Immunogen Inc shares in Q2 2014, an estimated $51K.
  • Tompkins Financial first reported a position in Immunogen Inc in Q2 2013 and held it in 4 quarters.
  • Tompkins Financial's Immunogen Inc position peaked at $58K in Q3 2013.
  • 137 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2014.

Based on Tompkins Financial's 13F filing for Q2 2014, filed 11 Jul 2014.